MDSteps Library Preview
You’ve viewed 0 of 3 free topics. Test the next topic with a free MDSteps reasoning diagnostic.
Try Free Diagnostic
MDSteps- USMLE® Reference Library

Preeclampsia and Eclampsia — ED Stabilization

System: Obstetrics Gynecology • Reviewed: Aug 14, 2026 • Step 1Step 2Step 3
Written by: Lynn Marinac, NP • Reviewed by: Jacob Aaron, MD

Synopsis:

Preeclampsia with severe features and eclampsia are obstetric emergencies that can progress rapidly to stroke, pulmonary edema, hepatic injury, placental abruption, fetal compromise, and death. ED priorities are maternal stabilization, treatment of persistent severe hypertension, magnesium sulfate for seizure prevention or treatment when indicated, rapid laboratory assessment, and immediate obstetric involvement for delivery planning.

Medical library → exam application

In OB/GYN, timing and safety often choose the answer.

Review the topic here, then practice how gestational age, stability, fetal status, contraindications, bleeding timing, or postpartum context changes management.

Timing clue used Safety checked Next step explained
Answer free sample questions and see how MDSteps identifies the decision patterns costing you points.

Key Points

  • Severe-range blood pressure in pregnancy or postpartum is a time-sensitive maternal stroke risk and should be treated promptly.
  • Preeclampsia can be diagnosed without proteinuria when hypertension is accompanied by qualifying end-organ dysfunction.
  • Eclampsia is treated first-line with magnesium sulfate, not with phenytoin as routine initial therapy.
  • Magnesium dosing requires close monitoring when renal function is impaired because toxicity risk increases.
  • HELLP syndrome may present with epigastric or right upper quadrant pain and can occur even when blood pressure abnormalities are not dramatic.
  • Fluid administration should be conservative and guided by clinical need because pulmonary edema is a recognized complication.
  • Preeclampsia and eclampsia can first present postpartum, including after discharge from the delivery hospitalization.
  • Delivery is definitive therapy but follows maternal stabilization and multidisciplinary obstetric planning.

Algorithm

  1. Confirm severe blood pressure promptly and assess airway, breathing, circulation, mental status, symptoms, gestational age, and postpartum status.
  2. Place IV access, obtain CBC, platelets, creatinine, liver tests, urine protein assessment, and additional studies based on presentation.
  3. Activate obstetrics and maternal-fetal medicine pathways and begin fetal assessment when appropriate.
  4. Treat persistent severe hypertension with IV labetalol, IV hydralazine, or immediate-release oral nifedipine according to protocol.
  5. Give magnesium sulfate for eclampsia and for seizure prophylaxis when severe features indicate it.
  6. Reassess blood pressure, neurologic status, respiratory status, urine output, reflexes, and fetal condition frequently.
  7. Treat pulmonary edema, hemorrhage, renal injury, HELLP syndrome, or other complications and obtain critical care support when needed.
  8. Proceed to delivery planning once maternal stabilization is underway; admit patients with severe features or eclampsia.

Clinical Synopsis & Reasoning

Preeclampsia is a pregnancy-specific hypertensive disorder that usually develops after 20 weeks of gestation and can also present postpartum. Hypertension with proteinuria is classic, but severe disease may be diagnosed with hypertension plus end-organ findings even without proteinuria. Severe features include persistent severe-range blood pressure, thrombocytopenia, renal insufficiency, impaired liver function with severe right upper quadrant or epigastric pain, pulmonary edema, or new neurologic or visual symptoms. Eclampsia is a new generalized seizure in a patient with preeclampsia when another cause is not more likely.

Emergency assessment should confirm blood pressure with correct cuff size and repeated measurements while simultaneously evaluating symptoms, gestational age, fetal status, and complications. Severe persistent hypertension, conventionally systolic 160 mm Hg or higher or diastolic 110 mm Hg or higher, requires urgent treatment because maternal stroke risk rises with sustained severe pressure. Headache, visual disturbance, dyspnea, chest pain, altered mental status, abdominal pain, vaginal bleeding, or decreased fetal movement require rapid escalation. Postpartum patients remain at risk and may present after hospital discharge.

Laboratory evaluation commonly includes CBC with platelets, creatinine, AST and ALT, bilirubin and LDH when hemolysis is suspected, urinalysis or urine protein assessment, and additional studies guided by the differential. HELLP syndrome involves hemolysis, elevated liver enzymes, and low platelets and may occur with or without dramatic hypertension. Consider intracranial hemorrhage, cerebral venous thrombosis, epilepsy, metabolic disease, toxic exposure, or posterior reversible encephalopathy when neurologic findings are atypical or persistent.


Treatment Strategy & Disposition

Treat ongoing severe hypertension promptly with an accepted first-line agent such as IV labetalol, IV hydralazine, or immediate-release oral nifedipine. Choice depends on access, contraindications, heart rate, asthma, and local obstetric protocols. The goal is to reduce the immediate risk of maternal cerebral and cardiovascular injury while avoiding abrupt hypotension that may impair uteroplacental perfusion. Continuous maternal reassessment and fetal monitoring should accompany treatment when gestational age and circumstances permit.

Magnesium sulfate is first-line therapy for treatment of eclamptic seizures and is used for seizure prophylaxis in preeclampsia with severe features according to obstetric guidance. A common regimen is a 4 to 6 g IV loading dose followed by 1 to 2 g/hour infusion. Monitor respiratory rate, reflexes, mental status, and urine output because magnesium is renally cleared. Calcium gluconate should be immediately available for clinically significant magnesium toxicity. Recurrent seizure despite magnesium requires obstetric, anesthesia, and critical care support and evaluation for an alternate or additional neurologic cause.

Definitive management is delivery, but timing depends on maternal stability, gestational age, fetal status, and obstetric assessment. The emergency clinician should not independently delay stabilization while awaiting a delivery plan. Admit all patients with eclampsia or severe features, and involve obstetrics immediately. Pulmonary edema requires oxygenation and ventilatory support with careful fluid management. Avoid routine aggressive crystalloid loading because endothelial dysfunction and capillary leak increase pulmonary edema risk.


Epidemiology / Risk Factors

  • Hypertensive disorders of pregnancy are major contributors to maternal morbidity and mortality worldwide.
  • Risk factors include prior preeclampsia, multifetal gestation, chronic hypertension, kidney disease, diabetes, autoimmune disease, and certain first-pregnancy or demographic factors.
  • Disease can arise antepartum, intrapartum, or postpartum, so recent delivery does not remove the diagnosis from consideration.
  • Severe maternal complications include stroke, pulmonary edema, acute kidney injury, hepatic injury or rupture, DIC, placental abruption, and eclampsia.
  • Fetal consequences are related to placental dysfunction, growth restriction, preterm delivery, and abruption.

Investigations

TestRole / RationaleTypical FindingsNotes
CBC with plateletsAssesses thrombocytopenia and hemoconcentrationLow platelets may indicate severe disease or HELLPTrend when disease is evolving
CreatinineAssesses renal involvementMay be elevatedReduced clearance increases magnesium toxicity risk
AST and ALTAssesses hepatic injuryMay be elevatedMarked elevation with RUQ pain raises concern for HELLP or hepatic complication
LDH, bilirubin, smearAssesses hemolysis when HELLP suspectedHemolysis markers may be abnormalUse with platelet and liver-enzyme pattern
Urine protein assessmentSupports diagnosis of proteinuric preeclampsiaElevated protein/creatinine ratio or proteinuriaAbsence of proteinuria does not exclude disease with severe end-organ features
UrinalysisAssesses protein and alternative renal pathologyProtein may be presentNot a substitute for complete clinical criteria
ECG/troponin/BNP as indicatedEvaluates cardiopulmonary symptomsVariableUse for chest pain, dyspnea, pulmonary edema, or suspected cardiomyopathy
Neuroimaging when indicatedEvaluates atypical seizure, focal deficit, or persistent altered stateMay show hemorrhage, PRES, thrombosis, or another processDo not delay seizure and blood pressure treatment while arranging imaging

Antihypertensive Options (ED)

DrugDose (example)Notes
IV labetalol20 mg IV initially, with protocol-based escalationAvoid or use caution with bradycardia, heart block, asthma, or decompensated heart failure
IV hydralazine5 to 10 mg IV, repeated per protocolMonitor for hypotension and tachycardia
Immediate-release nifedipine10 mg orally initially, repeated per protocolUseful when IV access is not available; do not administer sublingually

Pharmacology

MedicationMechanismOnsetRole in TherapyLimitations
Magnesium sulfateReduces recurrent eclamptic seizure risk and provides seizure prophylaxis in severe diseaseMinutesFirst-line anticonvulsant in eclampsiaRenal clearance; monitor for loss of reflexes, respiratory depression, and toxicity
Labetalol IVAlpha and beta adrenergic blockadeMinutesRapid treatment of severe hypertensionUse caution with bradycardia, heart block, decompensated heart failure, and reactive airway disease
Hydralazine IVDirect arteriolar vasodilatorMinutesAlternative rapid treatment of severe hypertensionCan produce headache, tachycardia, and hypotension
Nifedipine immediate release oralDihydropyridine calcium-channel blockadeMinutesRapid oral option when IV access is delayed or per protocolUse immediate-release oral formulation, not sublingual dosing

Prognosis / Complications

  • Outcome is generally favorable when severe hypertension and seizures are treated promptly and definitive obstetric care is available.
  • Stroke, pulmonary edema, HELLP syndrome, liver rupture, renal failure, and DIC markedly increase maternal risk.
  • Patients with a history of preeclampsia have increased long-term cardiovascular risk and need primary care follow-up after pregnancy.
  • Recurrence risk in a future pregnancy depends on gestational age and severity of prior disease and underlying maternal conditions.
  • Fetal prognosis is strongly influenced by gestational age, placental function, and whether urgent delivery is required.

Patient Education / Counseling

  • Explain that severe headache, visual changes, shortness of breath, chest pain, severe abdominal pain, seizure, or very high blood pressure after delivery require immediate evaluation.
  • Patients prescribed home blood pressure monitoring should receive clear thresholds and a specific plan for whom to contact.
  • Discuss medication adherence after discharge because antihypertensive therapy may be needed temporarily postpartum.
  • After recovery, patients should be informed that preeclampsia is associated with higher future cardiovascular risk and should be incorporated into long-term preventive care.
  • Future pregnancy planning should include early prenatal care and review of whether low-dose aspirin prevention is indicated.
  • Counsel that symptoms can recur or worsen after delivery and that delivery does not produce instantaneous resolution of maternal risk.

Notes

Persistent severe hypertension in pregnancy and postpartum should be treated as an emergency rather than a routine outpatient blood pressure problem. Therapy is directed at preventing maternal cerebrovascular and cardiopulmonary complications while obstetric specialists determine timing of delivery and ongoing monitoring.

A seizure in late pregnancy or the postpartum period should be presumed eclamptic when the clinical setting fits, while simultaneously considering alternative neurologic causes if the presentation is atypical.


References

  1. ACOG Gestational Hypertension and Preeclampsia — Link
  2. ACOG Severe Hypertension Resources — Link
Turn review into score movement

Turn OB/GYN review into patient-specific decisions.

Most students do not plateau because they refuse to study. They plateau because their review does not show the exact reasoning error behind repeated misses. MDSteps turns topic review into targeted blocks, explanations, flashcards, and readiness signals.

  • Full access to 1,100+ medical reference articles linked directly to relevant QBank concepts
  • 16,000+ USMLE-style questions across Step 1, Step 2 CK, and Step 3
  • Depth-on-Demand™ explanations that isolate the pivot clue, distractor trap, and decision point
  • CCS cases with live vitals, order timing, reassessment, and after-action feedback
Timing clue used Safety checked Next step explained

You’ve reached your MDSteps Library preview limit

Unlock the full Medical Library and use it the way it was built to work: alongside your QBank review, CCS practice, and personalized study tools.

  • Full access to 1,100+ medical reference articles linked directly to relevant QBank concepts
  • 16,000+ USMLE-style questions across Step 1, Step 2 CK, and Step 3
  • Depth-on-Demand™ explanations that isolate the pivot clue, distractor trap, and decision point
  • CCS cases with live vitals, order timing, reassessment, and after-action feedback